Hypera SA Financials
| HYPMY Stock | USD 3.67 0.31 9.23% |
Hypera |
Understanding current and past Hypera SA Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Hypera SA's financial statements are interrelated, with each one affecting the others. For example, an increase in Hypera SA's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Hypera SA's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Hypera SA. Check Hypera SA's Beneish M Score to see the likelihood of Hypera SA's management manipulating its earnings.
Hypera SA Stock Summary
Hypera SA competes with Cumberland Pharmaceuticals. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypermarcas ADR operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 9000 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US44914U1060 |
| Business Address | Av Magalhes de |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.hyperapharma.com.br |
| Phone | 55 11 3627 4206 |
| Currency | USD - US Dollar |
Hypera SA Key Financial Ratios
Hypera SA's financial ratios allow both analysts and investors to convert raw data from Hypera SA's financial statements into concise, actionable information that can be used to evaluate the performance of Hypera SA over time and compare it to other companies across industries.| Return On Equity | 0.16 | |||
| Return On Asset | 0.0686 | |||
| Beta | 0.24 | |||
| Last Dividend Paid | 1.23 |
Hypera Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Hypera SA's current stock value. Our valuation model uses many indicators to compare Hypera SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hypera SA competition to find correlations between indicators driving Hypera SA's intrinsic value. More Info.Hypera SA is rated # 4 in return on equity category among its peers. It also is rated # 4 in return on asset category among its peers reporting about 0.42 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Hypera SA is roughly 2.37 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Hypera SA by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Hypera SA's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Hypera SA Systematic Risk
Hypera SA's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Hypera SA volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Hypera SA correlated with the market. If Beta is less than 0 Hypera SA generally moves in the opposite direction as compared to the market. If Hypera SA Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Hypera SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Hypera SA is generally in the same direction as the market. If Beta > 1 Hypera SA moves generally in the same direction as, but more than the movement of the benchmark.
Hypera SA March 18, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Hypera SA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Hypera SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Hypera SA based on widely used predictive technical indicators. In general, we focus on analyzing Hypera Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Hypera SA's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.35 | |||
| Information Ratio | 0.0956 | |||
| Maximum Drawdown | 15.01 | |||
| Value At Risk | (2.83) | |||
| Potential Upside | 3.8 |
Additional Tools for Hypera Pink Sheet Analysis
When running Hypera SA's price analysis, check to measure Hypera SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hypera SA is operating at the current time. Most of Hypera SA's value examination focuses on studying past and present price action to predict the probability of Hypera SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hypera SA's price. Additionally, you may evaluate how the addition of Hypera SA to your portfolios can decrease your overall portfolio volatility.